XML 19 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
$ in Millions
Jun. 30, 2018
Dec. 31, 2017
Current assets    
Cash and cash equivalents $ 332 $ 83
Accounts receivable, net 808 797
Accrued unbilled revenues 648 764
Inventories 511 610
Regulatory assets 440 424
Derivative instruments 75 44
Prepaid taxes 78 68
Prepayments and other 164 183
Total current assets 3,056 2,973
Property, plant and equipment, net 35,289 34,329
Other assets    
Nuclear decommissioning fund and other investments 2,398 2,397
Regulatory assets 3,177 3,005
Derivative instruments 47 48
Other 273 278
Total other assets 5,895 5,728
Total assets 44,240 43,030
Current liabilities    
Current portion of long-term debt 856 457
Short-term debt 682 814
Accounts payable 1,092 1,243
Regulatory liabilities 395 239
Taxes accrued 316 448
Accrued interest 176 174
Dividends payable 193 183
Derivative instruments 27 29
Other 441 501
Total current liabilities 4,178 4,088
Deferred credits and other liabilities    
Deferred income taxes 3,973 3,845
Deferred investment tax credits 56 58
Regulatory liabilities 5,113 5,083
Asset retirement obligations 2,534 2,475
Derivative instruments 113 126
Customer advances 202 193
Pension and employee benefit obligations 884 1,042
Other 226 145
Total deferred credits and other liabilities 13,101 12,967
Commitments and contingencies
Capitalization    
Long-term debt 15,311 14,520
Common stock — 1,000,000,000 shares authorized of $2.50 par value; 508,898,420 and 507,762,881 shares outstanding at June 30, 2018 and Dec. 31, 2017, respectively 1,272 1,269
Additional paid in capital 5,920 5,898
Retained earnings 4,580 4,413
Accumulated other comprehensive loss (122) (125)
Total common stockholders’ equity 11,650 11,455
Total liabilities and equity $ 44,240 $ 43,030